Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luis Solís-Tarazona"'
Autor:
Luis Solís-Tarazona, Lars Lau Raket, Javier Cabello-Murgui, Salma Reddam, Silvia Navarro-Quevedo, Sara Gil-Perotin
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundThe assessment of serum neurofilament light chain (sNFL) has emerged as a diagnostic and prognostic tool in monitoring multiple sclerosis (MS). However, the application of periodic measurement in daily practice remains unclear.ObjectiveTo e
Externí odkaz:
https://doaj.org/article/24314e3bfa754b38beffded6b5fcf8a9
Autor:
Carmen Alcalá-Vicente, Francisco Pérez-Miralles, Sara Gil-Perotin, Luis Solís Tarazona, Hans Lassmann, Raquel Gasqué-Rubio, Jessica Castillo-Villalba, Laura Cubas-Nuñez, Sara Carratalà-Boscà, Verónica López, Bonaventura Casanova
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
article-version (Version of Record) 3
ObjectiveNeurofilament light protein (NfL) and chitinase 3–like 1 (CHI3L1) are biomarkers for acute neuroaxonal damage and local inflammation, respectively. Thus, we set out to evaluate how these biomarkers were associated with clinical features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5cd78f929d2c2bf24635c752fc93ab7
https://pubmed.ncbi.nlm.nih.gov/33658322
https://pubmed.ncbi.nlm.nih.gov/33658322
Autor:
Jéssica Castillo-Villalba, Sara Gil-Perotín, Raquel Gasque-Rubio, Laura Cubas-Nuñez, Sara Carratalà-Boscà, Carmen Alcalá, Carlos Quintanilla-Bordás, Francisco Pérez-Miralles, Cristina Ferrer, Antonio Cañada Martínez, Jordi Tortosa, Luís Solís-Tarazona, Luisa Campos, Alberto Leivas, Begoña Laíz Marro, Bonaventura Casanova
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cerebrospinal kappa free light chain (KFLC)-index is a marker of intrathecal immunoglobulin synthesis that aids in the diagnosis of multiple sclerosis (MS). However, little evidence exists on its prognostic role. Our aim is to analyze the relationshi
Externí odkaz:
https://doaj.org/article/b2a1c9817f794ef9b56f12e0b8ea37c3